Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Regulatory T cells are essential for normal and improved wound healing in mice.

Foxn1 gene regulation is crucial for thymus development but not for hair growth.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.